These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26216561)

  • 1. Psyclones: a roller coaster of life? Hidden synthetic cannabinoids and stimulants in apparently harmless products.
    Santacroce R; Corazza O; Martinotti G; Bersani FS; Valeriani G; Di Giannantonio M
    Hum Psychopharmacol; 2015 Jul; 30(4):265-71. PubMed ID: 26216561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Synthetic Cannabinoids Phenomenon.
    Karila L; Benyamina A; Blecha L; Cottencin O; Billieux J
    Curr Pharm Des; 2016; 22(42):6420-6425. PubMed ID: 27655416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Web searches to track interest in synthetic cannabinoids (a/k/a 'herbal incense').
    Curtis B; Alanis-Hirsch K; Kaynak Ö; Cacciola J; Meyers K; McLellan AT
    Drug Alcohol Rev; 2015 Jan; 34(1):105-8. PubMed ID: 25196534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Synthetic cannabinoids--the new "legal high" drugs].
    Berkovitz R; Arieli M; Marom E
    Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
    Dresen S; Ferreirós N; Pütz M; Westphal F; Zimmermann R; Auwärter V
    J Mass Spectrom; 2010 Oct; 45(10):1186-94. PubMed ID: 20857386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect and occurrence of synthetic cannabinoids].
    Tuv SS; Strand MC; Karinen R; Øiestad EL; Christophersen AS; Vindenes V
    Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2285-8. PubMed ID: 23736196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New designer drugs (synthetic cannabinoids and synthetic cathinones): review of literature.
    Cottencin O; Rolland B; Karila L
    Curr Pharm Des; 2014; 20(25):4106-11. PubMed ID: 24001292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spice/K2 drugs--more than innocent substitutes for marijuana.
    Zawilska JB; Wojcieszak J
    Int J Neuropsychopharmacol; 2014 Mar; 17(3):509-25. PubMed ID: 24169044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three fatalities associated with the synthetic cannabinoids 5F-ADB, 5F-PB-22, and AB-CHMINACA.
    Angerer V; Jacobi S; Franz F; Auwärter V; Pietsch J
    Forensic Sci Int; 2017 Dec; 281():e9-e15. PubMed ID: 29133010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring novel psychoactive substances allegedly offered online for sale in Persian and Arabic languages.
    Corazza O; Assi S; Malekianragheb S; Beni MN; Bigdeli I; Aslanpour Z; Schifano F
    Int J Drug Policy; 2014 Jul; 25(4):724-6. PubMed ID: 24917190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic cannabinoids: the dangers of spicing it up.
    Salani DA; Zdanowicz MM
    J Psychosoc Nurs Ment Health Serv; 2015 May; 53(5):36-43. PubMed ID: 25974923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quadrupole-time-of-flight mass spectrometry screening for synthetic cannabinoids in herbal blends.
    Ibáñez M; Bijlsma L; van Nuijs AL; Sancho JV; Haro G; Covaci A; Hernández F
    J Mass Spectrom; 2013 Jun; 48(6):685-94. PubMed ID: 23722959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spicing things up: synthetic cannabinoids.
    Spaderna M; Addy PH; D'Souza DC
    Psychopharmacology (Berl); 2013 Aug; 228(4):525-40. PubMed ID: 23836028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5,6-Methylenedioxy-2-aminoindane: from laboratory curiosity to 'legal high'.
    Gallagher CT; Assi S; Stair JL; Fergus S; Corazza O; Corkery JM; Schifano F
    Hum Psychopharmacol; 2012 Mar; 27(2):106-12. PubMed ID: 22389075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic cannabinoids: Variety is definitely not the spice of life.
    Langford AM; Bolton JR
    J Forensic Leg Med; 2018 Oct; 59():36-38. PubMed ID: 30130700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Some new psychoactive substances: precursor chemicals and synthesis-driven end-products.
    Collins M
    Drug Test Anal; 2011; 3(7-8):404-16. PubMed ID: 21755608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synthetic drugs: the new low-cost landscape of drugs].
    Karila L; Petit A; Cottencin O; Coscas S; Reynaud M
    Rev Prat; 2012 May; 62(5):664-6. PubMed ID: 22730798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthetic cannabinoids: A new addiction matrix].
    Scocard A; Benyamina A; Coscas S; Karila L
    Presse Med; 2017 Jan; 46(1):11-22. PubMed ID: 28063756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Spice drugs: cannabinoids as a new designer drugs].
    Mustata C; Torrens M; Pardo R; Pérez C; ; Farré M
    Adicciones; 2009; 21(3):181-6. PubMed ID: 19718488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Not for human consumption": a review of emerging designer drugs.
    Musselman ME; Hampton JP
    Pharmacotherapy; 2014 Jul; 34(7):745-57. PubMed ID: 24710806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.